Beta Bionics, which recently won FDA approval for its automated insulin dosing software, raised a $100M Series D, bringing its total funding to $293.5M (Andrea Park/Fierce Biotech)
Andrea Park / Fierce Biotech:
Beta Bionics, which recently won FDA approval for its automated insulin dosing software, raised a $100M Series D, bringing its total funding to $293.5M — In the wake of earning FDA clearance for its insulin pump an | In the wake of earning FDA clearance for its insulin pump and automated dosing software …